You are here

Article Text

Article menu
Download PDFPDF
BJO at a glance
BJO at a glance
  1. Creig Hoyt, Editor

    https://doi.org/10.1136/bjo.87.10.1199-a

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      TREATING SEASONAL ALLERGIC CONJUNCTIVITIS WITH KETOTIFEN

      Seasonal allergic conjunctivitis or hay fever conjunctivitis is a hypersensitivity reaction to specific airborne allergens, mainly pollens. It has a high prevalence rate and can be quite uncomfortable for the affected patient. A number of new topical treatments have been developed recently. Ketotifen blocks histamine H1 receptors, stabilises mass cells and prevents eosinophil accumulation. Kidd and coworkers report a double masked randomised multicentre trial conducted in Australia. In this study ketotifen 0.025% ophthalmic solution was well tolerated and effective in reducing the signs and symptoms of seasonal allergic conjunctivitis and in preventing recurrences. It consistently was most efficacious in comparison with a placebo and levocabastine. See p 1206

      CAN CORNEAL GRAFTING IN CHILDREN BE SUCCESSFUL?

      Successful restoration of vision with paediatric penetrating keratoplasty has only been achieved in the past two decades. In children the potential for post-surgical anterior segment inflammation that may accelerate graft rejection has been seen as …

      View Full Text

      Linked Articles